Ashish Kamat, Associated Editor at European Urology Oncology, shared on X:
“Looking forward to welcoming colleagues, friends, patient advocates, regulators, and industry partners to Houston this week for IBCG26. The strength of IBCG has always been honest discussion, respectful disagreement, and a shared commitment to improving bladder cancer care. Excited for two days of focused work together.
20 years ago, IBCG started with a small group around a table. Later this month, friends and colleagues from around the world gather in Houston for IBCG26. Two days around the table tackling some of the hardest questions in Bladder Cancer, debating the evidence and challenging each other on where we go next.
Looking forward to seeing you all!”
To which Sumanta Pal, Professor and Vice Chair of Academic Affairs, City of Hope, added:
“Excited for my first IBCG meeting next week! Hats off to Ashish M. Kamat and the exceptional team planning this event.
Looking forward to connecting!”
Ashish Kamat was recognized among OncoDaily’s The 100 Most Influential People in Oncology in 2025, highlighting his contributions to the field of oncology.
Nominations for 100 Influential People in Oncology 2026 are now open, recognizing leaders, researchers, clinicians, innovators, advocates, and other individuals making a meaningful impact on oncology and cancer care.
Don’t miss the opportunity to nominate yourself, a colleague, or someone whose contributions deserve to be recognized.
Submit your nomination by September 15: 100 Influential People in Oncology 2026 – Nominations are Open!
You can also read: Prognostic Value of Perioperative ctDNA Across Bladder Cancer Histologies
